ThomasNet News Logo
Sign Up | Log In | ThomasNet Home | Promote Your Business

New Advanced Process Data Management Software Turns Process Data into Information for Biopharmaceutical Process Development

Print | 
Email |  Comment   Share  

Applikon, Inc.
1165 Chess Dr., Suite G
Foster City, CA, 94404
USA



Press release date: June 22, 2014

Technology integration partner SecureCell delivers proven performance, versatility, and simplicity

DELFT — Applikon and SecureCell have signed an agreement for the worldwide marketing and sales of Advanced Process Information Management Software developed by SecureCell. The software allows the user to monitor and control bioprocesses and offers an extensive toolbox for analyzing process data cross platforms. Process information is generated based on data from different brands of bioreactors and a wide range of different cultivation volumes.

The software includes functionality for Design of Experiments, Reactor Planning, Media Preparation and Tracking, Parallel Processing, SCADA, Data Mining and Batch Reporting. The combination of the software with the broad range of Applikon Bioreactor Systems offers the user a unique system for validatable fast track development and basic research.

"The ever increasing amount of process data generated by more sensors in smaller parallel bioreactor systems needs advanced software to turn this data into useful information. With the SecureCell software we can offer a new dimension in data processing. Data management and data analysis is key for the future of R&D and process development in pharmaceutical industry. With this new software we are again leading the way in bioprocessing" said Erik Kakes, vice president of sales, Applikon Biotechnology.

"Applikon and SecureCell have a shared vision of the future of data management systems and we look forward to create solutions that integrate Applikon Bioreactors with our advanced software that has been developed over the past years in close cooperation with large pharmaceutical companies," said Carlo Andretta, CEO of SecureCell.

About Applikon Biotechnology
Applikon Biotechnology BV (Delft, Netherlands) is a privately owned leading supplier of bioreactor systems for the pharmaceutical and the biotechnological market. Since 1974 we specialize in novel technologies in cultivation systems, measurement and control for the biopharmaceutical industry. In the past 40 years, Applikon Biotechnology has built up a broad portfolio of unique bioprocessing devices for both cell culture and microbial cultivation, and this has considerably set us apart from the competition. We are definitely a step ahead.

To learn more about Applikon Biotechnology, visit www.applikon-biotechnology.com

About SecureCell

To learn more about SecureCell, visit www.securecell.ch

Contact information:
Erik Kakes
International Sales & Marketing Director
Applikon Biotechnology B.V.
Heertjeslaan 2, 2629 JG  Delft
The Netherlands
T: +31(0)10-208 35 55
F: +31(0)10-208 35 05
E: press@applikon-biotechnology.com
W: http://www.applikon-biotechnology.com



Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


 

Post a comment about this story

Name:
E-mail:
(your e-mail address will not be posted)
Comment title:
Comment:
To submit comment, enter the security code shown below and press 'Post Comment'.
 



 See related product stories
More .....
 See more product news in:
Software
 More New Product News from this company:
Control System targets bio-processing industry.
More ....
| Featured Manufacturing Jobs
 Tools for you
Watch Company 
View Company Profile
Company web site
More news from this company
E-mail this story to a friend
Save Story
Search for suppliers of
Process Control Software
Laboratory Information Management Software
Data Analysis Software
Join the forum discussion at:
Engineers Lounge


Home  |  My ThomasNet News®  |  Industry Market Trends®  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by Thomasnet.com        Browse ThomasNet Directory

Copyright © 2014 Thomas Publishing Company. All Rights Reserved.
Terms of Use - Privacy Policy



Error close

Please enter a valid email address